Skip to main content

Carson Advisory Inc.

Position in ABBV — AbbVie Inc.

CIK 1909304 ATHENS, GA

Position in ABBV

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$677,918
+$93,305 QoQ
Shares Held
2,694
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#2,904
of 4,153 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Carson Advisory Inc. holds $6,148,880 across 8 Drug Manufacturers - General names. ABBV ranks #3 (11.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ABBV
AbbVie Inc.
This page
2,694 $677,918

All Filings in ABBV

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $677,918 2,694
2026-03-31 $584,613 2,688
2025-12-31 $616,466 2,698
2025-09-30 $626,315 2,705
2025-06-30 $502,844 2,709
2025-03-31 $513,952 2,453
2024-12-31 $440,340 2,478
2024-09-30 $489,355 2,478
2024-06-30 $429,314 2,503
2024-03-31 $469,635 2,579
2023-12-31 $407,416 2,629
2023-09-30 $388,301 2,605
2023-06-30 $365,791 2,715
2023-03-31 $430,458 2,701
2022-12-31 $452,184 2,798
2022-09-30 $442,624 3,298
2022-06-30 $432,677 2,825
2022-03-31 $457,960 2,825
2021-12-31 $368,965 2,725